Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1889 1
1942 1
1943 1
1960 2
1961 1
1962 1
1963 3
1964 2
1965 3
1966 3
1967 4
1968 3
1969 3
1970 2
1971 3
1972 5
1973 7
1974 4
1975 3
1976 6
1977 8
1978 11
1979 6
1980 16
1981 14
1982 14
1983 14
1984 14
1985 19
1986 17
1987 15
1988 22
1989 20
1990 47
1991 41
1992 68
1993 70
1994 73
1995 64
1996 70
1997 66
1998 65
1999 106
2000 124
2001 173
2002 300
2003 405
2004 709
2005 774
2006 1296
2007 1289
2008 1390
2009 1484
2010 1698
2011 1583
2012 1605
2013 1671
2014 1848
2015 2048
2016 2104
2017 2121
2018 2134
2019 2390
2020 1371
Text availability
Article attribute
Article type
Publication date

Search Results

27,676 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Bingfei
Page 1
Did you mean xingfei pan (27 results)?
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.
Obeng S, Jali A, Zheng Y, Wang H, Schwienteck KL, Chen C, Stevens DL, Akbarali HI, Dewey WL, Banks ML, Liu-Chen LY, Selley DE, Zhang Y. Obeng S, et al. ACS Chem Neurosci. 2019 May 15;10(5):2518-2532. doi: 10.1021/acschemneuro.9b00038. Epub 2019 Feb 21. ACS Chem Neurosci. 2019. PMID: 30758946 Free PMC article.
NAN was identified as a low efficacy partial agonist for G-protein activation at the MOR and DOR, but had relatively high efficacy at the KOR. ...Overall, these results provide converging lines of evidence that NAN functions mainly as a MOR antagonist and support fu
NAN was identified as a low efficacy partial agonist for G-protein activation at the MOR and DOR, but had relatively high efficacy at
Special issue dedicated to Jack Kalbfleisch.
Schaubel DE, Nan B. Schaubel DE, et al. Lifetime Data Anal. 2018 Jan;24(1):1-2. doi: 10.1007/s10985-017-9416-1. Lifetime Data Anal. 2018. PMID: 29264748 Free PMC article. No abstract available.
Mutant KLF1 in Adult Anemic Nan Mice Leads to Profound Transcriptome Changes and Disordered Erythropoiesis.
Nébor D, Graber JH, Ciciotte SL, Robledo RF, Papoin J, Hartman E, Gillinder KR, Perkins AC, Bieker JJ, Blanc L, Peters LL. Nébor D, et al. Sci Rep. 2018 Aug 24;8(1):12793. doi: 10.1038/s41598-018-30839-2. Sci Rep. 2018. PMID: 30143664 Free PMC article.
Anemic Nan mice carry a mutation (E339D) in the second zinc finger of erythroid transcription factor KLF1. Nan-KLF1 fails to bind a subset of normal KLF1 targets and ectopically binds a large set of genes not normally engaged by KLF1, resulting in a corrupted fetal …
Anemic Nan mice carry a mutation (E339D) in the second zinc finger of erythroid transcription factor KLF1. Nan-KLF1 fails to b …
[Analysis of pesticide poisoning in Ji'nan during 2012-2016].
Peng XM, Cui YX, Cui LL, Zhou JW. Peng XM, et al. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2018 Mar 20;36(3):198-201. doi: 10.3760/cma.j.issn.1001-9391.2018.03.009. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2018. PMID: 29996221 Chinese.
Methods: The cases of pesticide poisoning from 2012 to 2016 were collected from medical institutions in Ji'nan, and the data was subjected to statistical analysis. ...Conclusion: Pesticide poisoning is a public health problem and social problem which is harmful to the heal …
Methods: The cases of pesticide poisoning from 2012 to 2016 were collected from medical institutions in Ji'nan, and the data was subj …
NAN-190, a possible specific antagonist for methamphetamine.
Ginawi OT, Al-Majed AA, Al-Suwailem AK. Ginawi OT, et al. Regul Toxicol Pharmacol. 2005 Mar;41(2):122-7. doi: 10.1016/j.yrtph.2004.10.005. Epub 2004 Dec 19. Regul Toxicol Pharmacol. 2005. PMID: 15698535
This was significantly antagonized by NAN-190 at a dose of 1 mg/kg, i.p. NAN-190 did not alter the antinociceptive activity of mice when it was administered alone. ...All of the above-studied activities of methamphetamine were antagonized by NAN-190, which ma …
This was significantly antagonized by NAN-190 at a dose of 1 mg/kg, i.p. NAN-190 did not alter the antinociceptive activity of …
Exosomes from C2C12 myoblasts enhance osteogenic differentiation of MC3T3-E1 pre-osteoblasts by delivering miR-27a-3p.
Xu Q, Cui Y, Luan J, Zhou X, Li H, Han J. Xu Q, et al. Biochem Biophys Res Commun. 2018 Mar 25;498(1):32-37. doi: 10.1016/j.bbrc.2018.02.144. Epub 2018 Feb 22. Biochem Biophys Res Commun. 2018. PMID: 29476741
Epidemiology of fragility hip fractures in Nan, Thailand.
Sucharitpongpan W, Daraphongsataporn N, Saloa S, Philawuth N, Chonyuen P, Sriruanthong K, Waiwattana K. Sucharitpongpan W, et al. Osteoporos Sarcopenia. 2019 Mar;5(1):19-22. doi: 10.1016/j.afos.2019.03.003. Epub 2019 Mar 17. Osteoporos Sarcopenia. 2019. PMID: 31008374 Free PMC article.
This study was aimed to describe the demographic data and to determine the incidence of fragility hip fractures in Nan, Thailand. ...RESULTS: The incidence of hip fractures in Nan province in 2015-2017 were 211.6, 214.9 and 238.5 per 100,000 person-years, respective …
This study was aimed to describe the demographic data and to determine the incidence of fragility hip fractures in Nan, Thailand. ... …
NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Rydelek-Fitzgerald L, Teitler M, Fletcher PW, Ismaiel AM, Glennon RA. Rydelek-Fitzgerald L, et al. Brain Res. 1990 Nov 5;532(1-2):191-6. doi: 10.1016/0006-8993(90)91759-a. Brain Res. 1990. PMID: 2282513
NAN-190 has been reported to be a 5-HT1A antagonist in drug discrimination studies. In order to determine if the effect of NAN-190 was directly due to competitive inhibition at 5-HT1A receptors, 5-HT1A-mediated inhibition of adenylyl cyclase in hippocampal membranes
NAN-190 has been reported to be a 5-HT1A antagonist in drug discrimination studies. In order to determine if the effect of NAN
Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma.
Zhang Q, Li Y, Miao C, Wang Y, Xu Y, Dong R, Zhang Z, Griffin BB, Yuan C, Yan S, Yang X, Liu Z, Kong B. Zhang Q, et al. Cancer Lett. 2018 Sep 28;432:144-155. doi: 10.1016/j.canlet.2018.05.049. Epub 2018 Jun 5. Cancer Lett. 2018. PMID: 29879497
27,676 results
Jump to page
Feedback